Inventaire - your friends and communities are your best library

Sirolimus-based graft-versus-host disease prophylaxis protects against cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation: a cohort analysis

author

Ingrid V Bassett

Lindsey R Baden

Joseph H Antin

published in: Blood

date of publication: 2007-03-28

language: English

main subject: Cytomegalovirus

Cites articles 54

Date

Title

Authors

2012-12-12

Lymphocyte phenotype during therapy for acute graft-versus-host disease: a brief report from BMT-CTN 0302

John E. Levine
2007-04-01

Extended follow-up of methotrexate-free immunosuppression using sirolimus and tacrolimus in related and unrelated donor peripheral blood stem cell transplantation

Joseph H Antin
2006-07-31

Control of human cytomegalovirus gene expression by differential histone modifications during lytic and latent infection of a monocytic cell line

Flora De Conto, Sergey Razin
2006-09-19

Human cytomegalovirus infection alters the substrate specificities and rapamycin sensitivities of raptor- and rictor-containing complexes
2006-05-01

Voriconazole and sirolimus coadministration after allogeneic hematopoietic stem cell transplantation

Lindsey R Baden, Joseph H Antin
2006-04-19

Target of rapamycin inhibitors (TOR-I; sirolimus and everolimus) for primary immunosuppression in kidney transplant recipients

Jonathan Craig, Angela Webster
2006-06-01

Pharmacokinetics of ganciclovir after oral valganciclovir versus intravenous ganciclovir in allogeneic stem cell transplant patients with graft-versus-host disease of the gastrointestinal tract.

Lindsey R Baden
2006-06-01

Tacrolimus with mycophenolate mofetil (MMF) or sirolimus vs. cyclosporine with MMF in cardiac transplant patients: 1-year report

Jon A Kobashigawa, Mark J. Zucker
2006-05-01

Valganciclovir is safe and effective as pre-emptive therapy for CMV infection in allogeneic hematopoietic stem cell transplantation
2006-01-01

Risk factors for the development of cytomegalovirus disease after allogeneic stem cell transplantation

Jerker Jonsson
2006-07-01

Latency and reactivation of human cytomegalovirus

John H Sinclair
2005-07-01

Sirolimus and thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation

Colm Magee, Stephanie J. Lee, Joseph H Antin
2005-02-28

Latency, chromatin remodeling, and reactivation of human cytomegalovirus in the dendritic cells of healthy carriers

John H Sinclair
2005-12-13

Oral valganciclovir leads to higher exposure to ganciclovir than intravenous ganciclovir in patients following allogeneic stem cell transplantation.

Gerhard Ehninger, Martin Bornhäuser, Hermann Einsele, Bernd Hertenstein
2004-09-30

Comparative outcome of nonmyeloablative and myeloablative allogeneic hematopoietic cell transplantation for patients older than 50 years of age.

Joseph H Antin, Jerome Ritz, Stephanie J. Lee
2004-10-01

Human cytomegalovirus infection induces rapamycin-insensitive phosphorylation of downstream effectors of mTOR kinase
2004-09-01

Sirolimus for GVHD prophylaxis in allogeneic stem cell transplantation
2004-12-01

Partial CD8+ T-cell depletion of allogeneic peripheral blood stem cell transplantation is insufficient to prevent graft-versus-host disease
2004-05-01

Sirolimus and tacrolimus without methotrexate as graft-versus-host disease prophylaxis after matched related donor peripheral blood stem cell transplantation

Stephanie J. Lee, Joseph H Antin
2004-01-01

Influence of cytomegalovirus (CMV) sero-positivity on CMV infection, lymphocyte recovery and non-CMV infections following T-cell-depleted allogeneic stem cell transplantation: a comparison between two T-cell depletion regimens
2003-11-26

The impact of cytomegalovirus serostatus of donor and recipient before hematopoietic stem cell transplantation in the era of antiviral prophylaxis and preemptive therapy

Michael Boeckh, W Garrett Nichols
2003-11-01

Comparison of DNA amplification, mRNA amplification, and DNA hybridization techniques for detection of cytomegalovirus in bone marrow transplant recipients

Francisco Diaz-Mitoma
2003-10-01

Prevention of cytomegalovirus disease in recipients of allogeneic stem cell transplants,Prevention of Cytomegalovirus Disease in Recipients of Allogeneic Stem Cell Transplants
2003-09-01

Cytomegalovirus in hematopoietic stem cell transplant recipients: Current status, known challenges, and future strategies

Michael Boeckh, W Garrett Nichols
2003-07-03

Immune reconstitution to cytomegalovirus after allogeneic hematopoietic stem cell transplantation: impact of host factors, drug therapy, and subclinical reactivation

Michael Boeckh, Lawrence Corey, Terry Stevens-Ayers, Stanley R Riddell
2003-12-01

Low incidence of cytomegalovirus disease in liver transplant recipients receiving sirolimus primary immunosuppression with 3-day corticosteroid taper
2003-11-01

Impact of unrelated donor status on the incidence and outcome of cytomegalovirus infections after non-myeloablative allogeneic stem cell transplantation

Michael Boeckh, Lawrence Corey, Rainer Storb, Brenda M Sandmaier, David G. Maloney, Christian Junghanss
2003-05-01

Sirolimus, tacrolimus, and low-dose methotrexate for graft-versus-host disease prophylaxis in mismatched related donor or unrelated donor transplantation

Joseph H Antin, Stephanie J. Lee
2003-01-16

Transfusion-transmitted cytomegalovirus infection after receipt of leukoreduced blood products

Michael Boeckh, Lawrence Corey, W Garrett Nichols
2002-06-01

Increased risk of complicated CMV infection with the use of mycophenolate mofetil in allogeneic stem cell transplantation
2002-03-01

Incidence and outcome of cytomegalovirus infections following nonmyeloablative compared with myeloablative allogeneic stem cell transplantation, a matched control study

Michael Boeckh, Lawrence Corey, Rainer Storb, Brenda M Sandmaier, Thomas R Chauncey, David G. Maloney, Christian Junghanss
2002-06-01

High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution

Ronjon Chakraverty, Charles Craddock, Herman Waldmann, Geoff Hale, David C Linch, Anthony H. Goldstone, Karl S Peggs, Panagiotis D Kottaridis, Suparno Chakrabarti, Premini Mahendra, Kwee L Yong, Stephen Mackinnon, Husam Osman, Christopher Fegan

Article - wd:Q35900978

Welcome to Inventaire

the library of your friends and communities

learn more